Series A startup

Who invested in BioGenes Technologies

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$5.7Mraised across 1 round since 2023, from 1 source

Latest round
Series A, $5.7MJan 2023
Investors
1
See who backed them

The rounds

  1. Jan 2023
    Series A$5.7M

    Source recorded

Founders and team

From BioGenes Technologies's own website: 7 on the team.

  • Adrian JosephCEO
  • Dr. Tam Yew JoonChief Scientific Officer
  • Tang Kok MunCOO
  • Afif Fahmi MustaffaBio Production Engineer
  • Hazana RazaliSenior Research Officer
  • Muhammad Aminur Afiq MazniBio Production Engineer
  • Teffanie ArputherajClinical Research Manager

Everyone who backed them

AntlerVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about BioGenes Technologies

Who invested in BioGenes Technologies?

BioGenes Technologies's investors include Antler.

How much has BioGenes Technologies raised?

BioGenes Technologies has raised $5.7M across 1 round since 2023.

When did BioGenes Technologies last raise?

BioGenes Technologies's most recent round was a Series A of $5.7M in Jan 2023.

What was BioGenes Technologies's biggest round?

Its most recent round, $5.7M in Jan 2023, is also its largest on record.

Who backed BioGenes Technologies first?

BioGenes Technologies's first round on record, in Jan 2023, was backed by Antler.

What stage is BioGenes Technologies at?

BioGenes Technologies's latest named round is a Series A, in Jan 2023.

Companies like BioGenes Technologies

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.